PT Suparma Tbk Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 857.91 billion. The enterprise value is 1.19 trillion.

Market Cap	857.91B
Enterprise Value	1.19T

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Suparma Tbk has 3.15 billion shares outstanding. The number of shares has increased by 1.36% in one year.

Current Share Class	n/a
Shares Outstanding	3.15B
Shares Change (YoY)	+1.36%
Shares Change (QoQ)	+2.90%
Owned by Insiders (%)	81.63%
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

The trailing PE ratio is 8.24.

PE Ratio	8.24
Forward PE	n/a
PS Ratio	0.32
PB Ratio	0.37
P/TBV Ratio	0.36
P/FCF Ratio	1.28
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.99, with an EV/FCF ratio of 1.77.

EV / Earnings	11.32
EV / Sales	0.43
EV / EBITDA	3.99
EV / EBIT	6.24
EV / FCF	1.77

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.25.

Current Ratio	2.83
Quick Ratio	1.01
Debt / Equity	0.25
Debt / EBITDA	2.04
Debt / FCF	0.90
Interest Coverage	4.87

Financial Efficiency

Return on equity (ROE) is 4.46% and return on invested capital (ROIC) is 4.00%.

Return on Equity (ROE)	4.46%
Return on Assets (ROA)	3.55%
Return on Invested Capital (ROIC)	4.00%
Return on Capital Employed (ROCE)	6.59%
Revenue Per Employee	3.45B
Profits Per Employee	132.54M
Employee Count	779
Asset Turnover	0.82
Inventory Turnover	2.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.29% in the last 52 weeks. The beta is 0.72, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-22.29%
50-Day Moving Average	279.56
200-Day Moving Average	296.03
Relative Strength Index (RSI)	49.44
Average Volume (20 Days)	117,170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.73 trillion and earned 104.84 billion in profits. Earnings per share was 33.00.

Revenue	2.73T
Gross Profit	412.85B
Operating Income	190.05B
Pretax Income	134.44B
Net Income	104.84B
EBITDA	297.72B
EBIT	190.05B
Earnings Per Share (EPS)	33.00

Full Income Statement

Balance Sheet

The company has 277.71 billion in cash and 606.30 billion in debt, giving a net cash position of -328.59 billion or -104.18 per share.

Cash & Cash Equivalents	277.71B
Total Debt	606.30B
Net Cash	-328.59B
Net Cash Per Share	-104.18
Equity (Book Value)	2.38T
Book Value Per Share	734.77
Working Capital	927.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 710.80 billion and capital expenditures -39.31 billion, giving a free cash flow of 671.49 billion.

Operating Cash Flow	710.80B
Capital Expenditures	-39.31B
Free Cash Flow	671.49B
FCF Per Share	212.89

Full Cash Flow Statement

Margins

Gross margin is 15.12%, with operating and profit margins of 6.96% and 3.84%.

Gross Margin	15.12%
Operating Margin	6.96%
Pretax Margin	4.93%
Profit Margin	3.84%
EBITDA Margin	10.91%
EBIT Margin	6.96%
FCF Margin	24.60%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.41%.

Dividend Per Share	12.00
Dividend Yield	4.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	36.02%
Buyback Yield	-1.36%
Shareholder Yield	3.05%
Earnings Yield	12.22%
FCF Yield	78.27%

Dividend Details

Stock Splits

The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.

Last Split Date	Jun 15, 2022
Split Type	Forward
Split Ratio	1.13

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a